Ernst L Noordraven
Overview
Explore the profile of Ernst L Noordraven including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
57
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Noordraven E, Wierdsma A, Blanken P, Bloemendaal A, Mulder C
BMC Res Notes
. 2018 Sep;
11(1):655.
PMID: 30201054
Objective: Offering a financial incentive ('Money for Medication') is effective in improving adherence to treatment with depot antipsychotic medications. We investigated the cost-effectiveness in terms of medical costs and judicial...
2.
Noordraven E, Wierdsma A, Blanken P, Bloemendaal A, Mulder C
BMC Psychiatry
. 2018 May;
18(1):144.
PMID: 29793451
Background: Offering financial incentives is an effective intervention for improving adherence in patients taking antipsychotic depot medication. We assessed whether patients' motivation for treatment might be reduced after receiving financial...
3.
Noordraven E, Schermer M, Blanken P, Mulder C, Wierdsma A
BMC Psychiatry
. 2017 Aug;
17(1):313.
PMID: 28851345
Background: A randomized controlled trial 'Money for Medication'(M4M) was conducted in which patients were offered financial incentives for taking antipsychotic depot medication. This study assessed the attitudes and ethical considerations...
4.
Noordraven E, Wierdsma A, Blanken P, Bloemendaal A, Staring A, Mulder C
Lancet Psychiatry
. 2017 Feb;
4(3):199-207.
PMID: 28236956
Background: Provision of financial incentives is a promising intervention for improving adherence in patients taking antipsychotic medication. We aimed to assess the effectiveness of this intervention for improving adherence to...
5.
Noordraven E, Wierdsma A, Blanken P, Bloemendaal A, Mulder C
Neuropsychiatr Dis Treat
. 2016 Feb;
12:269-74.
PMID: 26893565
Background: Noncompliance is a major problem for patients with a psychotic disorder. Two important risk factors for noncompliance that have a severe negative impact on treatment outcomes are impaired illness...
6.
Noordraven E, Audier C, Staring A, Wierdsma A, Blanken P, van der Hoorn B, et al.
BMC Psychiatry
. 2014 Dec;
14:343.
PMID: 25438877
Background: Non-adherence with antipsychotic medication is a frequently occurring problem, particularly among patients with psychotic disorders. Prior research has generally shown encouraging results for interventions based on 'Contingency Management' (CM),...